Complement 1
Dover
About Complement 1
Complement 1 is a health technology company dedicated to transforming cancer care through lifestyle medicine. Founded in 2024, Complement 1 has developed the first clinically validated, tech-enabled lifestyle program with daily 1:1 coaching for cancer patients, survivors, and those at high risk. By combining personalized coaching with evidence-based interventions in exercise, nutrition, and somatic practices, Complement 1 helps patients improve their projected quality of life. Backed by leading oncologists and scientific research, Complement 1’s platform integrates seamlessly with conventional oncology care to deliver better outcomes and empower patients in their healing journey. The company is headquartered in the U.S. with a mission to make effective, holistic cancer care accessible to all. For more information, visit complement1.com.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $16.0M
- Funding stage: Seed
- Last round: Seed (Apr 2025)
- Website: complement1.com
- Phone: [email protected]
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/complement-1-56264 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.